In general, the pharmacokinetic model parameters, like rate constants,
area under the curve (AUG) etc. are estimated via a two-stage procedu
re, where the values obtained from concentration-time relationships wi
thin one subject (experimental unit) are considered to be functionally
related to the drug concentrations measured. In many cases 'mean' est
imators and their respective standard errors are calculated afterwards
. The determination of drug concentrations in organs as well as in the
serum of small animals (mice, rats) in dependence of the time after a
dministration often does not permit the establishment of reasonable pr
ofiles within one subject suited for conventional pharmacokinetic anal
yses and tolerability studies. Frequently, only one experimental value
per organ or animal is recorded. The consequence is that most pharmac
okinetic parameters are to be estimated on the basis of the mean conce
ntrations rather than via the mean of individual parameter estimates.
In all cases of a non-linear relationship between a target item and th
e concentration, the mean-concentration based estimators and the two-s
tage profile based estimators need not coincide. In addition, in the f
ormer case variance estimators may be either difficult to obtain or no
t deducible. In order to get variance estimators as well as to enable
comparisons between different treatment regimens, in addition to bioeq
uivalence testing as a step towards human dose finding studies, variou
s resampling techniques (parametric and non-parametric bootstrap) were
applied to generate pseudo-profiles from independent measurements and
compared to their more conventional counterparts where applicable. Si
mulation studies based on different predefined pharmacokinetic models
(first-order elimination after IV bolus, first-order elimination after
first-order absorption, simple capacity-limited kinetics) revealed th
at even the non-parametric pseudo-profile stratified 'bootstrap' (resa
mpling with replacement per time point) performs quite satisfactorily.